SMARCA2 and diabetes mellitus: The analysis identified six significant gene sets at the diabetes studies and the combined datasets, including “UV response”, “chronic myelogenous leukemia”, “KLF1 targets”, “SMARCA2 targets”, “Alzheimer’s disease” and “stromal stem cells”.